摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

diethyl 2-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl)-ethylphosphonate | 201854-47-9

中文名称
——
中文别名
——
英文名称
diethyl 2-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl)-ethylphosphonate
英文别名
diethyl 2-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl)-ethyl phosphonate;Diethyl 2-(2,3,4,6-tetra-O-acetyl-alpha-D-galactopyranosyl)-ethylphosphonate;[(2R,3S,4R,5S,6R)-3,4,5-triacetyloxy-6-(2-diethoxyphosphorylethyl)oxan-2-yl]methyl acetate
diethyl 2-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl)-ethylphosphonate化学式
CAS
201854-47-9
化学式
C20H33O12P
mdl
——
分子量
496.449
InChiKey
CHOMDLXCBWOWJC-SWBPCFCJSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    538.0±40.0 °C(Predicted)
  • 密度:
    1.25±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    33
  • 可旋转键数:
    16
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    150
  • 氢给体数:
    0
  • 氢受体数:
    12

反应信息

  • 作为反应物:
    描述:
    diethyl 2-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl)-ethylphosphonate吡啶四氮唑三甲基溴硅烷 作用下, 以 甲醇乙腈 为溶剂, 反应 257.0h, 生成 bis(triethylammonium) [2-(α-D-galactopyranosyl)-ethylphosphono]uridin-5'-yl phosphate
    参考文献:
    名称:
    Non-isosteric C-glycosyl analogues of natural nucleotide diphosphate sugars as glycosyltransferase inhibitors
    摘要:
    A series of C-glycosyl ethylphosphonophosphate analogues of UDP-Glc, UDP-Gal, UDP-GlcNAc and GDP-Fuc were synthesized from the corresponding C-glycosyl ethylphosphonic acids. Analogues were obtained as alpha-anomers through either diastereoselective photo-induced radical addition of glycosyl bromides (D-Glc, D-Gal and L-Fuc) to diethyl vinylphosphonate, or a multi-step sequence (D-GlcNAc), with subsequent coupling with morpholidate-activated nucleotide monophosphates. The in vitro inhibitory activity of UDP-Gal, GDP-Fuc and UDP-GlcNAc analogues towards glycosyltransferases (beta-1,4-Gaff, FUT3 and LgtA) was evaluated through a competition fluorescence assay and IC50 values of 40 mu M, 2 mM and 3.5 mM were obtained, respectively. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2006.06.057
  • 作为产物:
    描述:
    alpha-D-半乳糖三丁基氯化锡氢溴酸 、 sodium cyanoborohydride 、 叔丁醇 作用下, 以 吡啶乙醚溶剂黄146 为溶剂, 反应 116.0h, 生成 diethyl 2-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl)-ethylphosphonate
    参考文献:
    名称:
    [EN] DERIVATIVES OF URIDINE PHOSPHATE AND THEIR USES IN PROTEIN BINDING ASSAYS
    [FR] COMPOSÉS ET LEURS UTILISATIONS DANS DES DOSAGES DE LIAISON AUX PROTÉINES
    摘要:
    公开号:
    WO2011051733A3
点击查看最新优质反应信息

文献信息

  • Towards α- or β-d-C-glycosyl compounds by tin-catalyzed addition of glycosyl radicals to acrylonitrile and vinylphosphonate, and flexible reduction of tetra-O-acetyl-α-d-glucopyranosyl bromide with cyanoborohydride
    作者:Jean-Pierre Praly、Azin Salek Ardakani、Isabelle Bruyère、Chrystelle Marie-Luce、Bing Bing Qin
    DOI:10.1016/s0008-6215(02)00052-6
    日期:2002.10
    These conditions led to 2-(α- d -manno-, and galactopyranosyl)-ethylphosphonates in 68 and 76% yields. Similarly, radical addition of acetylated 1-bromo-β- d -glucopyranosyl chloride ( 2 ) to acrylonitrile or diethyl vinylphosphonate afforded mainly intermediate chlorides which, upon radical reduction with excess tri- n -butyltin hydride, afforded the corresponding β anomers (40 and 38%, respectively)
    摘要在催化量的化三正丁基锡和过量的氰基硼氢化钠(或四正丁基)存在下,将乙酰化的α-d-葡萄糖化物(1)光诱导自由基加成到丙烯腈乙烯基膦酸乙酯中,可以高效制备α-构型的壬腈和2-(α-d-葡萄糖基)-乙基膦酸酯(产率分别为79%和70%)。这些条件导致产率为68%和76%的2-(α-d-甘露糖基和喃并喃糖基)-乙基膦酸酯。类似地,将乙酰化的1--β-d-葡萄糖(2)自由基加成到丙烯腈乙烯基膦酸乙酯中,主要得到中间体化物,在用过量的三正丁基锡氢化物进行自由基还原后,得到相应的β异构体(40和分别由38%的CC和CH键形成。立体控制依赖于d -glycopyranos-1-yl自由基的α-立体选择性猝灭。我们还发现,在叔丁醇中用过量的NaBH 3 CN进行1的紫外光辐照,可得到1,3,4,6-四-O-乙酰基-2-脱氧-α-d-阿拉伯糖-己喃糖(结晶后占65%
  • The first C-glycosidic analogue of a novel galactosyltransferase inhibitor
    作者:Karine Descroix、Gerd K. Wagner
    DOI:10.1039/c0ob00630k
    日期:——
    Structural analogues and mimics of the natural sugar-nucleotide UDP-galactose (UDP-Gal) are sought after as chemical tools for glycobiology and drug discovery. We have recently developed a novel class of galactosyltransferase (GalT) inhibitors derived from UDP-Gal, bearing an additional substituent at the 5-position of the uracil base. Herein we report the first C-glycosidic derivative of this new
    天然糖核苷酸的结构类似物和模拟物 UDP-半乳糖UDP-Gal作为糖生物学和药物发现的化学工具而受到追捧。我们最近开发了一种新型的半乳糖基转移酶(GalT)抑制剂,其衍生自UDP-Gal,在尿嘧啶碱基的5-位带有一个附加的取代基。在本文中,我们报道了这种新型的GalT抑制剂的第一个C-糖苷衍生物。我们描述了新的UDP-C-Gal衍生物的实用收敛合成,包括对自由基化学用于制备半乳糖乙基膦酸酯(一种关键的合成中间体)的系统研究。新抑制剂在微摩尔浓度下显示出对细菌UDP-Gal 4'-表异构酶的活性。这是碱基修饰的UDP糖作为不是糖基转移酶的UDP糖依赖性酶的抑制剂的第一个例子,因此这些结果可能对将来设计这些酶的抑制剂有影响。
  • DERIVATIVES OF URIDINE PHOSPHATE AND THEIR USES IN PROTEIN BINDING ASSAYS
    申请人:Wagner Gerd
    公开号:US20120219963A1
    公开(公告)日:2012-08-30
    The present invention relates to compounds and their use in competitive protein binding assays, for example for use with glycosyl transferase and/or glycoprocessing proteins. The present application also provides kits and apparatuses for use in the assays. In particular, the present invention provides a compound of the formula (I): wherein n is 1, 2 or 3; R 1 is selected from —OH, —OPO 3 H, —OR 4 , —NHR 4 , R 6 ; R 2 and R 3 are each independently selected from —H, —OH, optionally substituted —O-alkyl and —O-alkanoyl; R 4 is selected from an optionally substituted mono or polysaccharide, -alkyl, -alkenyl, -alkynyl, and L-Z, where L is a linking agent and Z is a binding agent; R 6 is an optionally substituted hydrocarbon group; A is either (i) a substituted heteroaryl group, the substituent on the heteroaryl group having a double bond conjugated to the heteroaryl group, or (ii) a substituted aryl group, the substituent on the aryl group having a double bond conjugated to the aryl group.
    本发明涉及化合物及其在竞争性蛋白结合测定中的应用,例如用于糖基转移酶和/或糖基加工蛋白的应用。本申请还提供用于该测定的试剂盒和装置。具体而言,本发明提供式(I)的化合物:其中n为1、2或3;R1选择自—OH、—OPO3H、—OR4、—NHR4、R6;R2和R3各自独立地选择自—H、—OH、可选地取代的—O-烷基和—O-酰基烷基;R4选择自可选地取代的单糖多糖、-烷基、-烯基、-炔基和L-Z,其中L是连接剂,Z是结合剂;R6是可选地取代的烃基;A是(i)取代的杂环芳基,杂环芳基上的取代基具有共轭到杂环芳基的双键,或(ii)取代的芳基,芳基上的取代基具有共轭到芳基的双键。
  • Derivatives of uridine phosphate and their uses in protein binding assays
    申请人:Wagner Gerd
    公开号:US09018370B2
    公开(公告)日:2015-04-28
    The present invention relates to compounds and their use in competitive protein binding assays, for example for use with glycosyl transferase and/or glycoprocessing proteins. The present application also provides kits and apparatuses for use in the assays. In particular, the present invention provides a compound of the formula (I): wherein n is 1, 2 or 3; R1 is selected from —OH, —OPO3H, —OR4, —NHR4, R6; R2 and R3 are each independently selected from —H, —OH, optionally substituted —O-alkyl and —O-alkanoyl; R4 is selected from an optionally substituted mono or polysaccharide, -alkyl, -alkenyl, -alkynyl, and L-Z, where L is a linking agent and Z is a binding agent; R6 is an optionally substituted hydrocarbon group; A is either (i) a substituted heteroaryl group, the substituent on the heteroaryl group having a double bond conjugated to the heteroaryl group, or (ii) a substituted aryl group, the substituent on the aryl group having a double bond conjugated to the aryl group.
    本发明涉及化合物及其在竞争性蛋白质结合测定中的应用,例如用于糖基转移酶和/或糖基加工蛋白质的应用。本申请还提供用于该测定的试剂盒和设备。具体而言,本发明提供了式(I)的化合物:其中n为1、2或3;R1选自—OH、—OPO3H、—OR4、—NHR4、R6;R2和R3各自独立地选自—H、—OH、可选地取代的—O-烷基和—O-酰基烷基;R4选自可选地取代的单糖多糖、-烷基、-烯基、-炔基和L-Z,其中L是连接剂,Z是结合剂;R6是可选地取代的碳氢基团;A是(i)取代的杂芳基团,杂芳基团上的取代基具有与杂芳基团共轭的双键,或(ii)取代的芳基团,芳基团上的取代基具有与芳基团共轭的双键。
  • Diastereoselective synthesis of C-glycosylphosphonates via free-radical glycosylation
    作者:Hans-Dieter Junker、Wolf-Dieter Fessner
    DOI:10.1016/s0040-4039(97)10498-1
    日期:1998.1
    A single step approach for the diastereoselective synthesis of C-glycosidic sugar phosphonates was developed by utilizing a free radical coupling to dialkyl vinylphosphonates to give the title compounds in moderate yield. The method is broadly applicable to sugars, deoxysugars, aminosugars, and oligosaccharides. (C) 1997 Elsevier Science Ltd. All rights reserved.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸